NCT05132036

Brief Summary

Determination of the hemodialysis ultrafiltration volume is guided by the clinician's estimate of dry weight. A poor estimate of this dry weight may result in insufficient fluid depletion causing a state of volume overload, which may be associated with long-term left ventricular failure, high blood pressure and excess of mortality. The diagnosis of fluid overload in haemodialysis patient is routinely based on clinical examination which consists of cardiopulmonary auscultation and edema palpation of limb member. Clinical examination can be completed by paraclinical examinations, and bioimpedance is an objective tool that assess fluid overload state. This test provides an individualized hydration status and fluid overload based on normal extracellular volume considering body composition. Echocardiography allows an accurate assessment of blood volume status by simultaneous studying left ventricular filling pressures, systolic pulmonary artery pressure and the diameter of the inferior vena cava. Lung ultrasound analyses the B-lines defined as artefactual images resulting from contact between air in "alveoli" and water in "septa". It can estimate pulmonary congestion. The aim of the study is to evaluate the lung ultrasound using "8 sites" score accuracy for estimating fluid overload of patients before hemodialysis session.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2021

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 23, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

November 19, 2025

Status Verified

November 1, 2025

Enrollment Period

7 months

First QC Date

November 16, 2021

Last Update Submit

November 17, 2025

Conditions

Keywords

Lung ultrasoundHemodialysis Complicationhemodialysis ultrafiltration volume

Outcome Measures

Primary Outcomes (1)

  • number of patients with fluid overload

    Fluid overloaded are determined by both tecniques : estimated fluid overload and lung ultrasound measured fluid overload

    one day

Interventions

Subjects are enrolled during their usual session in the hemodialysis unit of the Amiens University Hospital. Before starting the hemodialysis, lung ultrasound according to the "8 sites" score and a measure of bioimpedance will be performed in dorsal decubitus. In a 2nd time, an echocardiography is realized. During haemodialysis session, biological analysis and clinical score will be assessed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years old
  • patients on hemodialysis for more than 3 months;
  • patients without cardiological or infectious event for at least 3 months;
  • patients having at least 2 dialysis session per week;
  • patients affiliated with a health insurance plan;
  • patients having signed an informed consent.

You may not qualify if:

  • Pulmonary fibrosis or active lung disease;
  • residual diuresis over 500 mL per day;
  • body mass index (BMI) \< 21 and \> 28 Kg/m²;
  • medical history of major amputation (subgonal or transfemoral);
  • pacemaker carrier;
  • patients with orthopedic prosthesis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2021

First Posted

November 23, 2021

Study Start

November 9, 2021

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

November 19, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations